Your browser doesn't support javascript.
loading
An IRF1-IRF4 Toggle-Switch Controls Tolerogenic and Immunogenic Transcriptional Programming in Human Langerhans Cells.
Davies, James; Vallejo, Andres F; Sirvent, Sofia; Porter, Gemma; Clayton, Kalum; Qumbelo, Yamkela; Stumpf, Patrick; West, Jonathan; Gray, Clive M; Chigorimbo-Murefu, Nyaradzo T L; MacArthur, Ben; Polak, Marta E.
Affiliation
  • Davies J; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Vallejo AF; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Sirvent S; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Porter G; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Clayton K; Clinical and Experimental Sciences, Sir Henry Wellcome Laboratories, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Qumbelo Y; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Stumpf P; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • West J; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • Gray CM; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Chigorimbo-Murefu NTL; Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.
  • MacArthur B; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Polak ME; Division of Immunology, Institute of Infectious Disease and Molecular Medicine, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Front Immunol ; 12: 665312, 2021.
Article in En | MEDLINE | ID: mdl-34211464
ABSTRACT
Langerhans cells (LCs) reside in the epidermis as a dense network of immune system sentinels, coordinating both immunogenic and tolerogenic immune responses. To determine molecular switches directing induction of LC immune activation, we performed mathematical modelling of gene regulatory networks identified by single cell RNA sequencing of LCs exposed to TNF-alpha, a key pro-inflammatory signal produced by the skin. Our approach delineated three programmes of LC phenotypic activation (immunogenic, tolerogenic or ambivalent), and confirmed that TNF-alpha enhanced LC immunogenic programming. Through regulon analysis followed by mutual information modelling, we identified IRF1 as the key transcription factor for the regulation of immunogenicity in LCs. Application of a mathematical toggle switch model, coupling IRF1 with tolerance-inducing transcription factors, determined the key set of transcription factors regulating the switch between tolerance and immunogenicity, and correctly predicted LC behaviour in LCs derived from different body sites. Our findings provide a mechanistic explanation of how combinatorial interactions between different transcription factors can coordinate specific transcriptional programmes in human LCs, interpreting the microenvironmental context of the local tissue microenvironments.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Langerhans Cells / Tumor Necrosis Factor-alpha / Interferon Regulatory Factors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Langerhans Cells / Tumor Necrosis Factor-alpha / Interferon Regulatory Factors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article Affiliation country: